| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 19.904 | 42.816 | 77.934 | 111.329 | 77.421 | 113.277 | 173.275 | 167.808 | 141.008 |
| Total Income - EUR | 0 | 19.914 | 43.260 | 77.984 | 111.861 | 77.698 | 129.793 | 173.541 | 167.950 | 141.989 |
| Total Expenses - EUR | 0 | 10.325 | 37.200 | 57.733 | 108.069 | 74.816 | 128.608 | 130.109 | 125.555 | 121.643 |
| Gross Profit/Loss - EUR | 0 | 9.589 | 6.060 | 20.251 | 3.792 | 2.881 | 1.186 | 43.432 | 42.396 | 20.345 |
| Net Profit/Loss - EUR | 0 | 9.246 | 4.841 | 19.487 | 2.671 | 2.083 | 38 | 41.704 | 40.968 | 16.885 |
| Employees | 0 | 1 | 1 | 1 | 2 | 3 | 4 | 4 | 3 | 3 |
Check the financial reports for the company - Agrosimab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 5.029 | 6.862 | 5.046 | 3.299 | 9.983 | 7.232 | 20.799 | 17.924 |
| Current Assets | 57 | 9.118 | 17.409 | 34.412 | 65.435 | 64.997 | 52.806 | 115.516 | 125.791 | 101.688 |
| Inventories | 0 | 0 | 1.472 | 1.299 | 17.389 | 19.174 | 18.940 | 325 | 453 | 450 |
| Receivables | 0 | 0 | 7.511 | 9.743 | 17.066 | 44.943 | 17.879 | 68.185 | 117.044 | 89.837 |
| Cash | 57 | 9.118 | 8.426 | 23.370 | 30.980 | 879 | 15.987 | 47.006 | 8.294 | 11.401 |
| Shareholders Funds | -1.541 | 7.723 | 8.056 | 27.255 | 26.622 | 19.795 | 89 | 41.753 | 75.014 | 20.963 |
| Social Capital | 45 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 1.598 | 1.395 | 14.383 | 14.019 | 43.859 | 48.502 | 62.700 | 80.995 | 71.576 | 98.649 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7731 - 7731" | |||||||||
| CAEN Financial Year |
7731
|
|||||||||
Comments - Agrosimab Srl